Desvenlafaxine Succinate Monohydrate


Indications and Reactions:

Role Indications Reactions
Primary
Major Depression 31.6%
Hypertension 13.9%
Depression 8.6%
Bursitis 6.7%
Headache 4.8%
Menopausal Symptoms 4.8%
Anxiety 4.3%
Arthralgia 2.9%
Dyspepsia 2.9%
Gastrooesophageal Reflux Disease 2.9%
Back Pain 2.4%
Hypercholesterolaemia 2.4%
Blood Cholesterol Increased 1.9%
Cardiovascular Event Prophylaxis 1.4%
Constipation 1.4%
Dyslipidaemia 1.4%
Folliculitis 1.4%
Hormone Replacement Therapy 1.4%
Hypothyroidism 1.4%
Insomnia 1.4%
Suicide Attempt 22.7%
Suicidal Ideation 13.3%
Neutropenia 8.0%
Atrial Fibrillation 6.7%
Drug Exposure During Pregnancy 5.3%
Pulmonary Embolism 5.3%
Swollen Tongue 5.3%
Anxiety 4.0%
Completed Suicide 4.0%
Muscle Twitching 4.0%
Anterior Chamber Disorder 2.7%
Drug Ineffective 2.7%
Intentional Overdose 2.7%
Irritability 2.7%
Mental Disorder 2.7%
Tremor 2.7%
Abnormal Behaviour 1.3%
Abnormal Dreams 1.3%
Aggression 1.3%
Blood Pressure Decreased 1.3%
Secondary
Major Depression 12.6%
Bursitis 10.9%
Hypertension 10.9%
Ill-defined Disorder 10.4%
Menopausal Symptoms 9.1%
Drug Use For Unknown Indication 5.2%
Anxiety 4.8%
Gastrooesophageal Reflux Disease 4.3%
Depression 3.5%
Fibromyalgia 3.5%
Insomnia 3.0%
Cardiovascular Event Prophylaxis 2.6%
Constipation 2.6%
Dyslipidaemia 2.6%
Hypothyroidism 2.6%
Pruritus 2.6%
Smoking Cessation Therapy 2.6%
Hypercholesterolaemia 2.2%
Product Used For Unknown Indication 2.2%
Bipolar Disorder 1.7%
Atrial Fibrillation 18.0%
Suicide Attempt 18.0%
Anterior Chamber Disorder 8.0%
Swollen Tongue 8.0%
Epstein-barr Virus Infection 6.0%
Headache 4.0%
Hepatomegaly 4.0%
Infectious Mononucleosis 4.0%
Neck Pain 4.0%
Polymedication 4.0%
Suicidal Ideation 4.0%
Completed Suicide 2.0%
Drug Exposure During Pregnancy 2.0%
Heart Rate Increased 2.0%
Irritability 2.0%
Loss Of Consciousness 2.0%
Mental Status Changes 2.0%
Migraine 2.0%
Nausea 2.0%
Off Label Use 2.0%

Drug Data